Matthew Chuter is a Senior Director in Corporate Legal at AstraZeneca, having transitioned into this role in 2024. Previously, they gained extensive experience in corporate law at MedImmune from 2013 to 2016, where they were responsible for complex IP licensing transactions and strategic counsel on various collaboration projects. Matthew began their legal career as a trainee solicitor at Mayer Brown from 2007 to 2009 and completed internships at several law firms in 2005. They earned a distinction from the College of Law, Guildford, between 2006 and 2007.
This person is not in any teams
This person is not in any offices